vs

Side-by-side financial comparison of Dave Inc. (DAVE) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Dave Inc. is the larger business by last-quarter revenue ($163.7M vs $83.1M, roughly 2.0× PROCEPT BioRobotics Corp). Dave Inc. runs the higher net margin — 40.3% vs -38.1%, a 78.3% gap on every dollar of revenue. On growth, Dave Inc. posted the faster year-over-year revenue change (62.4% vs 20.2%). Over the past eight quarters, Dave Inc.'s revenue compounded faster (49.1% CAGR vs 24.8%).

Dave & Buster's Entertainment, Inc. is an American restaurant and entertainment business headquartered in Dallas. Each Dave & Buster's location has a full-service restaurant, full bar, and a video arcade, the latter of which is known as the "Million Dollar Midway". As of February 2024, the company has 158 locations in the United States, as well as two in Puerto Rico and two in Canada.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

DAVE vs PRCT — Head-to-Head

Bigger by revenue
DAVE
DAVE
2.0× larger
DAVE
$163.7M
$83.1M
PRCT
Growing faster (revenue YoY)
DAVE
DAVE
+42.2% gap
DAVE
62.4%
20.2%
PRCT
Higher net margin
DAVE
DAVE
78.3% more per $
DAVE
40.3%
-38.1%
PRCT
Faster 2-yr revenue CAGR
DAVE
DAVE
Annualised
DAVE
49.1%
24.8%
PRCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DAVE
DAVE
PRCT
PRCT
Revenue
$163.7M
$83.1M
Net Profit
$65.9M
$-31.6M
Gross Margin
64.9%
Operating Margin
39.2%
-4.1%
Net Margin
40.3%
-38.1%
Revenue YoY
62.4%
20.2%
Net Profit YoY
292.4%
-27.9%
EPS (diluted)
$4.60
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DAVE
DAVE
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$163.7M
$76.4M
Q3 25
$150.7M
$83.3M
Q2 25
$131.8M
$79.2M
Q1 25
$108.0M
$69.2M
Q4 24
$100.8M
$68.2M
Q3 24
$92.5M
$58.4M
Q2 24
$80.1M
$53.4M
Net Profit
DAVE
DAVE
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$65.9M
$-29.8M
Q3 25
$92.1M
$-21.4M
Q2 25
$9.0M
$-19.6M
Q1 25
$28.8M
$-24.7M
Q4 24
$16.8M
$-18.9M
Q3 24
$466.0K
$-21.0M
Q2 24
$6.4M
$-25.6M
Gross Margin
DAVE
DAVE
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
DAVE
DAVE
PRCT
PRCT
Q1 26
-4.1%
Q4 25
39.2%
-40.6%
Q3 25
38.8%
-27.8%
Q2 25
8.7%
-28.0%
Q1 25
31.4%
-39.7%
Q4 24
17.3%
-28.9%
Q3 24
0.9%
-38.4%
Q2 24
5.7%
-50.3%
Net Margin
DAVE
DAVE
PRCT
PRCT
Q1 26
-38.1%
Q4 25
40.3%
-39.1%
Q3 25
61.1%
-25.7%
Q2 25
6.9%
-24.7%
Q1 25
26.7%
-35.8%
Q4 24
16.7%
-27.6%
Q3 24
0.5%
-35.9%
Q2 24
7.9%
-48.0%
EPS (diluted)
DAVE
DAVE
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$4.60
$-0.54
Q3 25
$6.34
$-0.38
Q2 25
$0.62
$-0.35
Q1 25
$1.97
$-0.45
Q4 24
$1.09
$-0.34
Q3 24
$0.03
$-0.40
Q2 24
$0.47
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DAVE
DAVE
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$80.5M
$245.6M
Total DebtLower is stronger
$0
$51.7M
Stockholders' EquityBook value
$352.7M
$347.7M
Total Assets
$487.4M
$487.1M
Debt / EquityLower = less leverage
0.00×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DAVE
DAVE
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$80.5M
$286.5M
Q3 25
$49.9M
$294.3M
Q2 25
$61.8M
$302.7M
Q1 25
$47.1M
$316.2M
Q4 24
$49.8M
$333.7M
Q3 24
$35.2M
$196.8M
Q2 24
$48.7M
$214.1M
Total Debt
DAVE
DAVE
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$0
$51.6M
Q3 25
$75.0M
$51.6M
Q2 25
$75.0M
$51.5M
Q1 25
$75.0M
$51.5M
Q4 24
$75.0M
$51.5M
Q3 24
$75.0M
$51.4M
Q2 24
$75.0M
$51.4M
Stockholders' Equity
DAVE
DAVE
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$352.7M
$365.9M
Q3 25
$291.3M
$380.3M
Q2 25
$217.1M
$385.8M
Q1 25
$199.5M
$389.2M
Q4 24
$183.1M
$402.2M
Q3 24
$155.8M
$241.2M
Q2 24
$141.8M
$251.8M
Total Assets
DAVE
DAVE
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$487.4M
$508.1M
Q3 25
$433.3M
$511.5M
Q2 25
$363.6M
$513.1M
Q1 25
$315.7M
$519.4M
Q4 24
$299.3M
$534.0M
Q3 24
$272.2M
$374.1M
Q2 24
$247.2M
$374.4M
Debt / Equity
DAVE
DAVE
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.00×
0.14×
Q3 25
0.26×
0.14×
Q2 25
0.35×
0.13×
Q1 25
0.38×
0.13×
Q4 24
0.41×
0.13×
Q3 24
0.48×
0.21×
Q2 24
0.53×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DAVE
DAVE
PRCT
PRCT
Operating Cash FlowLast quarter
$290.0M
Free Cash FlowOCF − Capex
$289.7M
FCF MarginFCF / Revenue
177.0%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
4.40×
TTM Free Cash FlowTrailing 4 quarters
$486.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DAVE
DAVE
PRCT
PRCT
Q1 26
Q4 25
$290.0M
$-10.3M
Q3 25
$83.2M
$-6.6M
Q2 25
$68.2M
$-15.0M
Q1 25
$45.2M
$-17.0M
Q4 24
$125.1M
$-32.4M
Q3 24
$37.0M
$-18.8M
Q2 24
$28.0M
$-15.7M
Free Cash Flow
DAVE
DAVE
PRCT
PRCT
Q1 26
Q4 25
$289.7M
$-12.2M
Q3 25
$83.2M
$-9.5M
Q2 25
$68.1M
$-17.8M
Q1 25
$45.2M
$-18.8M
Q4 24
$124.9M
$-33.6M
Q3 24
$37.0M
$-19.0M
Q2 24
$27.9M
$-16.8M
FCF Margin
DAVE
DAVE
PRCT
PRCT
Q1 26
Q4 25
177.0%
-15.9%
Q3 25
55.2%
-11.4%
Q2 25
51.7%
-22.5%
Q1 25
41.9%
-27.2%
Q4 24
123.8%
-49.2%
Q3 24
40.0%
-32.6%
Q2 24
34.8%
-31.4%
Capex Intensity
DAVE
DAVE
PRCT
PRCT
Q1 26
Q4 25
0.2%
2.4%
Q3 25
0.0%
3.4%
Q2 25
0.1%
3.5%
Q1 25
0.0%
2.7%
Q4 24
0.3%
1.7%
Q3 24
0.1%
0.4%
Q2 24
0.2%
2.0%
Cash Conversion
DAVE
DAVE
PRCT
PRCT
Q1 26
Q4 25
4.40×
Q3 25
0.90×
Q2 25
7.55×
Q1 25
1.57×
Q4 24
7.45×
Q3 24
79.47×
Q2 24
4.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DAVE
DAVE

Service Based Revenue$153.2M94%
Interchange Revenue Net$6.4M4%
Transaction Based Revenue Other Net$4.1M3%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons